Exane Derivatives’s Suncor Energy SU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-2
Closed -$65 908
2022
Q1
$65 Buy
+2
New +$59 ﹤0.01% 996
2021
Q4
Sell
-2
Closed -$41 960
2021
Q3
$41 Hold
2
﹤0.01% 1037
2021
Q2
$45 Hold
2
﹤0.01% 1037
2021
Q1
$42 Hold
2
﹤0.01% 873
2020
Q4
$34 Hold
2
﹤0.01% 818
2020
Q3
$24 Hold
2
﹤0.01% 744
2020
Q2
$34 Hold
2
﹤0.01% 676
2020
Q1
$32 Hold
2
﹤0.01% 688
2019
Q4
$69 Hold
2
﹤0.01% 663
2019
Q3
$63 Hold
2
﹤0.01% 639
2019
Q2
$62 Hold
2
﹤0.01% 647
2019
Q1
$65 Hold
2
﹤0.01% 592
2018
Q4
$56 Hold
2
﹤0.01% 651
2018
Q3
$78 Sell
2
-3,000
-100% -$121K ﹤0.01% 631
2018
Q2
$120K Hold
3,002
0.02% 311
2018
Q1
$103K Hold
3,002
0.02% 297
2017
Q4
$110K Hold
3,002
0.02% 285
2017
Q3
$106K Hold
3,002
0.02% 250
2017
Q2
$87.8K Hold
3,002
0.02% 283
2017
Q1
$92.7K Hold
3,002
0.02% 231
2016
Q4
$98.5K Buy
3,002
+3,000
+150,000% +$91.9K 0.02% 252
2016
Q3
$56 Hold
2
﹤0.01% 558
2016
Q2
$55 Hold
2
﹤0.01% 485
2016
Q1
$56 Hold
2
﹤0.01% 547
2015
Q4
$52 Hold
2
﹤0.01% 468
2015
Q3
$53 Hold
2
﹤0.01% 501
2015
Q2
$55 Hold
2
﹤0.01% 502
2015
Q1
$58 Hold
2
﹤0.01% 498
2014
Q4
$64 Buy
+2
New +$66 ﹤0.01% 506

Other funds holding SU

Exane Derivatives's SU Position: Q2 2022 in Review

Exane Derivatives sold out of Suncor Energy (SU) in Q2 2022, closing a stake of 2 shares — an estimated $65 sold.

Exane Derivatives first reported a position in SU in Q4 2014 and held it in 29 quarters. The position peaked at $120K in Q2 2018. 577 funds tracked by Wall St. Rank hold SU as of Q2 2022.

  • Exane Derivatives reported no remaining Suncor Energy position as of Q2 2022 after selling out during the quarter.
  • Exane Derivatives sold 2 Suncor Energy shares in Q2 2022, an estimated $65.
  • Exane Derivatives first reported a position in Suncor Energy in Q4 2014 and held it in 29 quarters.
  • Exane Derivatives's Suncor Energy position peaked at $120K in Q2 2018.
  • 577 funds tracked by Wall St. Rank held Suncor Energy as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.